ClinicalTrials.gg
WithdrawnNCT06110364Updated Oct 26, 2024

Vagal Nerve Stimulation as an Alternative Therapy for Premature Ventricular Contractions

A Phase 3 interventional study of Low-Level Tragus Stimulation and Heart Rate Variability- Biofeedback in Premature Ventricular Contraction, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-26.

Sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center · Phase 3, Interventional, and Treatment

Why this study was withdrawn
Study Closed due to funding; no subjects enrolled

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2023, registered Oct 2023).
Phase
Phase 3
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Prospective randomized control pilot study

Read the detailed description

The primary aims of this investigator initiated study is :

Aim 1: to assess the ability of non-invasive vagal nerve stimulation to suppress Premature Ventricular Contractions and Aim 2: to compare the efficacy of Lower-level Tragus stimulation and Heart rate variability- Biofeedback in suppression of Premature Ventricular Contractions.

02

Conditions studied

  • Premature Ventricular Contraction

Keywords

  • NIVNS Non-invasive vagal nerve stimulation
  • LLTS- Low-level tragus stimulation
  • HRV-BF - Heart rate variability biofeedback
03

In context

Ventricular Premature Complexes

102 studies on the registry are indexed under Ventricular Premature Complexes; 32 are open to participants now.

Browse Ventricular Premature Complexes studies →

Lead sponsor

Hunter Holmes Mcguire Veteran Affairs Medical Center is the lead sponsor of 31 studies on the registry; 1 is open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 2 (29%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Normal Left Ventricular systolic function
  • Frequent PVCs

Exclusion criteria

Exclusion Criteria:

  • Current use of any (I and/or III) antiarrhythmic medication
  • to use beta blockers and non-dihydropyridine calcium channel blockers
  • Complete Atrioventricular block and pacemaker dependent
  • Ongoing uncontrolled hypertension with systolic Blood Pressure> 180
  • Family history of dilated Cardiomyopathy in a first degree relative
  • Alcohol use disorder or illicit drug use
  • Actively being treated Atrial fibrillation/ Flutter with Rapid Ventricular Response
  • Moderate to severe valve disorders
  • Patient with shortwave/microwave therapy equipment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Low-Level Tragus Stimulation

    The Low-Level Tragus Stimulation will be done with TENS.

    Device: Low-Level Tragus Stimulation

  • Experimental
    Heart Rate Variability- Biofeedback

    Heart Rate Variability-Biofeedback will be done with a phone application. Practice sessions are at least 10-15 minutes twice a daily.

    Behavioral: Heart Rate Variability- Biofeedback

  • Active comparator
    Conventional Medical Therapy

    Subjects without beta blockers will be initiated on a usual/standard care medication of beta blockers to determine the efficacy of this standard medication therapy for Premature Ventricular Contraction suppression.

    Other: Conventional Medical Therapy

Interventions

  • DeviceLow-Level Tragus Stimulation

    Low-Level Tragus Stimulation via TENS unit will be monitored with a Holter.

    Also known as: TENS

  • BehavioralHeart Rate Variability- Biofeedback

    Heart Rate Variability- Biofeedback will be monitored with a Holter.

    Also known as: Breathing Exercises / Inner Balance

  • OtherConventional Medical Therapy

    Conventional Medical Therapy by Beta Blockers will be added to subjects usual care by their doctor if they are not already taking this medication.

    Also known as: Usual care medication

06

What researchers measure

Primary outcomes

  1. Assess the ability of non-invasive vagal nerve stimulation to suppress Premature Ventricular Contractions.

    Compare the effects of Premature Ventricular Contractions suppression between standard medical therapy and non-invasive vagal nerve stimulation.

    Time frame: perspective 12-week study (each arm lasting two weeks with a one week washout between each arm)

Secondary outcomes

  1. Compare the efficacy of non-invasive vagal nerve stimulation via lower-level vagal stimulation and heart rate variability in suppression of Premature Ventricular Contractions.

    It is speculated that Heart Rate Variability-Biofeedback is as effective as Lower Level Tragus Stimulation to achieve successful Premature Ventricular Contraction suppression.

    Time frame: perspective 12-week study (each arm lasting two weeks with a one-week washout between each arm)

07

Study locations

1 site
  • Richmond VA Medical Center
    Richmond, Virginia 23249, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06110364
Lead sponsor
Hunter Holmes Mcguire Veteran Affairs Medical Center
Responsible party
Jose Huizar (Associate Chief of Staff for Research and Development at VAMC, Professor of Medicine at VCU, Director, Arrhythmia and Device Clinic at VAMC and Affiliate Professor of Physiology and Biophysics VCU, Hunter Holmes Mcguire Veteran Affairs Medical Center) — Principal investigator
First posted
Oct 31, 2023
Start date
Jul 19, 2023
Primary completion
Jul 30, 2024
Completion
Aug 13, 2024
Last update
Oct 26, 2024

Study contacts

Jose Huizar, M.D.
principal investigator · Hunter Holmes McGuire Veterans Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion